Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Medicines Company (MDCO)

Medicines Company (MDCO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
84.90 -0.06 (-0.07%) 01/03/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 84.90 unch (unch) -
Quote Overview for Fri, Jan 3rd, 2020
Day Low
84.88
Day High
84.98
Open 84.96
Previous Close 84.96 84.96
Volume 15,594,700 15,594,700
Avg Vol 3,385,805 3,385,805
Stochastic %K 95.91% 95.91%
Weighted Alpha +302.10 +302.10
5-Day Change +0.19 (+0.22%) +0.19 (+0.22%)
52-Week Range 17.81 - 84.98 17.81 - 84.98
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,768,482
  • Shares Outstanding, K 79,723
  • Annual Sales, $ 6,140 K
  • Annual Income, $ -123,160 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.10
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.98
  • Most Recent Earnings $-0.72 on 10/30/19
  • Next Earnings Date 02/26/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.90
  • Number of Estimates 6
  • High Estimate -0.74
  • Low Estimate -1.19
  • Prior Year -0.67
  • Growth Rate Est. (year over year) -34.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.88 +1.22%
on 12/05/19
Period Open: 84.10
84.98 -0.09%
on 01/03/20
+0.80 (+0.95%)
since 12/03/19
3-Month
48.96 +73.41%
on 10/04/19
Period Open: 50.03
84.98 -0.09%
on 01/03/20
+34.87 (+69.70%)
since 10/03/19
52-Week
17.81 +376.70%
on 01/04/19
Period Open: 17.86
84.98 -0.09%
on 01/03/20
+67.04 (+375.36%)
since 01/03/19

Most Recent Stories

More News
Pfizer and Sanofi shares fall, which one to scoop up?

Pharmaceutical stocks aren't having a banner year; notably, two large pharmaceutical companies recently plunged to 52-week lows

SNYNF : 106.0200 (+2.00%)
SAN : 6.70 (-0.45%)
MDCO : 84.90 (-0.07%)
PFE : 22.04 (-0.45%)
SNY : 50.93 (+0.06%)
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?

Eli Lilly & Co. stock has been on a tear, trading up 57.7% year-to-date on the strength of its industry-leading medications and highly-anticipated pipeline

C : 62.69 (-0.89%)
NVO : 58.33 (+0.43%)
MDCO : 84.90 (-0.07%)
LLY : 818.02 (-2.61%)
7 Best Cancer Stocks to Invest in Now

The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.

BGNE : 184.71 (+0.49%)
MDCO : 84.90 (-0.07%)
MRK : 77.85 (-0.19%)
AZN.LN : 10,124.000 (-1.27%)
EXEL : 35.59 (-1.66%)
NVS : 110.54 (-0.29%)
KURA : 6.18 (+4.75%)
GILD : 104.33 (-0.20%)
PFE : 22.04 (-0.45%)
ON : 34.74 (+0.29%)
Attralus Therapeutics Appoints Mark Timney as CEO and Expands Leadership Team with New Executives

Attralus Therapeutics today announced the appointment of Mark Timney as the company’s Chief Executive Officer and a member of its Board of Directors. Timney brings to Attralus more than 30 years of...

MDCO : 84.90 (-0.07%)
NVS : 110.54 (-0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 85.02
1st Resistance Point 84.96
Last Price 84.90
1st Support Level 84.86
2nd Support Level 84.82
3rd Support Level N/A

See More

52-Week High 84.98
Last Price 84.90
Fibonacci 61.8% 59.32
Fibonacci 50% 51.40
Fibonacci 38.2% 43.47
52-Week Low 17.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro